BHBjörn Hanf

Björn Hanf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Björn Hanf has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nucleoside diphosphate kinase A (NME1) catalyses its own oligophosphorylation

    by Arif Celik, Felix Schöpf, Christian E. Stieger, Sarah Lampe, Björn Hanf, Jeremy A. M. Morgan, Max Ruwolt, Fan Liu, Christian P. R. Hackenberger, Daniel Roderer, et al.

    Protein phosphorylation is a central signalling mechanism in eukaryotic cells. The scope of this post-translational modification includes protein pyro- and polyphosphorylation. Here we report the discovery of another mode of phosphorylation: protein oligophosphorylation. Using site-specifically phosphorylated and pyrophosphorylated nucleoside diphosphate kinase A (NME1), the effects of these modifications on enzyme activity were investigated. Phosphorylation, and more so pyrophosphorylation, on Thr94 reduced the nucleoside diphosphate kinase activity. Nevertheless, both phosphoprotein and pyrophosphoprotein catalysed their own oligophosphorylation—up to the formation of a hexaphosphate chain—using ATP as a cofactor. Oligophosphorylation was critically dependent on the catalytic histidine residue His118, and cryogenic electron microscopy analysis of the modified proteins suggests an intramolecular phosphoryl transfer mechanism. Oligophosphorylation of NME1 in biochemical samples, and in cell lysates, was further confirmed using mass spectrometry, and was found to promote a new set of protein interactions. Our results highlight the complex nature of phosphoregulation, and the methods described here provide the opportunity to investigate the impact of this unusual modification in the future.


  • Open Access

    Monodisperse Chemical Oligophosphorylation of Peptides via Protected Oligophosphorimidazolide Reagents

    by Kevin Qian, Björn Hanf, Christopher Cummins, Dorothea Fiedler

    Protein poly‐ and oligophosphorylation are recently discovered post‐translational modifications that remain poorly characterized due to (1) the difficulty of extracting endogenously polyphosphorylated species without degradation and (2) the absence of synthetic and analytical tools to prepare and characterize poly‐ and oligophosphorylated species in biochemical contexts. Herein, we report a methodology for the selective oligophosphorylation of peptides with monodisperse phosphate chain lengths (P n =3–6). A library of oligophosphorimidazolide (oligoP‐imidazolide) reagents featuring benzyl and o ‐nitrophenylethyl protecting groups was synthesized in moderate‐to‐good yields (65–93 %). These oligoP‐imidazolide reagents enabled the selective and simultaneous conjugation of multiple phosphate units to phosphoryl nucleophiles, circumventing tedious iterative processes. The generalizability of this approach is illustrated by a substrate scope study that includes several biologically relevant phosphopeptide sequences, culminating in the synthesis of >60 examples of peptide oligophosphates (P n =2–6). Moreover, we report the preparation of oligoP‐diimidazolides (P n =3–5) and discuss their application in generating unique condensed phosphate‐peptide conjugates. We also demonstrate that human phospho‐ubiquitin (pS65‐Ub) is amenable to functionalization by our reagents. Overall, we envision the methods described here will enable future studies that characterize these newly discovered but poorly understood phosphorylation modes.

  • Open Access

    Monodisperse Chemical Oligophosphorylation of Peptides via Protected Oligophosphorimidazolide Reagents

    by Kevin Qian, Björn Hanf, Christopher Cummins, Dorothea Fiedler

    Protein poly‐ and oligophosphorylation are recently discovered post‐translational modifications that remain poorly characterized due to (1) the difficulty of extracting endogenously polyphosphorylated species without degradation and (2) the absence of synthetic and analytical tools to prepare and characterize poly‐ and oligophosphorylated species in biochemical contexts. Herein, we report a methodology for the selective oligophosphorylation of peptides with monodisperse phosphate chain lengths (P n =3–6). A library of oligophosphorimidazolide (oligoP‐imidazolide) reagents featuring benzyl and o ‐nitrophenylethyl protecting groups was synthesized in moderate‐to‐good yields (65–93 %). These oligoP‐imidazolide reagents enabled the selective and simultaneous conjugation of multiple phosphate units to phosphoryl nucleophiles, circumventing tedious iterative processes. The generalizability of this approach is illustrated by a substrate scope study that includes several biologically relevant phosphopeptide sequences, culminating in the synthesis of >60 examples of peptide oligophosphates (P n =2–6). Moreover, we report the preparation of oligoP‐diimidazolides (P n =3–5) and discuss their application in generating unique condensed phosphate‐peptide conjugates. We also demonstrate that human phospho‐ubiquitin (pS65‐Ub) is amenable to functionalization by our reagents. Overall, we envision the methods described here will enable future studies that characterize these newly discovered but poorly understood phosphorylation modes.